AI

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

Jim Cornall - August 19, 2026

AI

11 start-ups selected for Irish AI accelerator programme

admin - May 13, 2024

AI

Researcher in Norway increases 6G network capacity

Jim Cornall - May 6, 2024

AI

Boost for security in artificial intelligence and image processing

Jim Cornall - April 29, 2024

AI

AI tool can measure work-related stress

Jim Cornall - March 28, 2024

AI

AI infrastructure survey reveals GPU challenges

Jim Cornall - March 15, 2024

AI

Ten ways AI will shape the next five years

Jim Cornall - January 17, 2024

AI

Oman uses AI to relay real-time election results to citizens

Jim Cornall - November 13, 2023

AI

Can AI change aviation with guaranteed safe landings?

Jim Cornall - October 18, 2023

1...567 Page 6 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026 0

This week, we have a conversation about the Flexible Automation for Scalable Health (FLASH) programme, focused on the development of scalable cell-free DNA bioproduction...

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0

Pilot project between BioCytics and LIDE Biotech

biotech Jim Cornall - August 19, 2026 0